Evidence map›Paper›PMID 30442128›Full record

ArticleRespiratory research2018

Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury.

Shengtian Mu, Yina Liu, Jing Jiang, Renyu Ding, Xu Li, Xin Li, Xiaochun Ma

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. A 3-Frontiers in immunology · 2023
    Article
  18. Protective Effects ofInternational journal of molecular sciences · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shengtian MuDepartment of Intensive Care Unit, The First Affiliated Hospital of China Medical University, No. 92 Bei-er Road, Shenyang, 110001, Liaoning Province, People's Republic of China.
Yina LiuDepartment of Intensive Care Unit, The First Affiliated Hospital of China Medical University, No. 92 Bei-er Road, Shenyang, 110001, Liaoning Province, People's Republic of China.
Jing JiangDepartment of Intensive Care Unit, The First Affiliated Hospital of China Medical University, No. 92 Bei-er Road, Shenyang, 110001, Liaoning Province, People's Republic of China.
Renyu DingDepartment of Intensive Care Unit, The First Affiliated Hospital of China Medical University, No. 92 Bei-er Road, Shenyang, 110001, Liaoning Province, People's Republic of China.
Xu LiDepartment of Intensive Care Unit, The First Affiliated Hospital of China Medical University, No. 92 Bei-er Road, Shenyang, 110001, Liaoning Province, People's Republic of China.
Xin LiDepartment of Intensive Care Unit, The First Affiliated Hospital of China Medical University, No. 92 Bei-er Road, Shenyang, 110001, Liaoning Province, People's Republic of China.
Xiaochun MaDepartment of Intensive Care Unit, The First Affiliated Hospital of China Medical University, No. 92 Bei-er Road, Shenyang, 110001, Liaoning Province, People's Republic of China. mxc_icu@126.com.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndothelial barrier dysfunction is central to the pathogenesis of sepsis-associated acute lung injury (ALI). Microtubule (MT) dynamics in vascular endothelium are crucial for the regulation of endothelial barrier function. Unfractionated heparin (UFH) possesses various biological activities, such as anti-inflammatory activity and endothelial barrier protection during sepsis.

methodsHere, we investigated the effects and underlying mechanisms of UFH on lipopolysaccharide (LPS)-induced endothelial barrier dysfunction. C57BL/6 J mice were randomized into vehicle, UFH, LPS and LPS + UFH groups. Intraperitoneal injection of 30 mg/kg LPS was used to induce sepsis. Mice in the LPS + UFH group received intravenous UFH 0.5 h prior to LPS injection. Human pulmonary microvascular endothelial cells (HPMECs) were cultured for analyzing the effects of UFH on LPS-induced and nocodazole-induced hyperpermeability, F-actin remodeling, and LPS-induced p38 MAPK activation.

resultsUFH pretreatment significantly attenuated LPS-induced pulmonary histopathological changes, and increased the lung W/D ratio and Evans blue accumulation in vivo. Both in vivo and in vitro studies showed that UFH pretreatment blocked the LPS-induced increase in guanine nucleotide exchange factor (GEF-H1) expression and myosin phosphatase target subunit 1 (MYPT1) phosphorylation, and microtubule (MT) disassembly in LPS-induced ALI mouse model and human pulmonary microvascular endothelial cells (HPMECs). These results suggested that UFH ameliorated LPS-induced endothelial barrier dysfunction by inhibiting MT disassembly and GEF-H1 expression. In addition, UFH attenuated LPS-induced hyperpermeability of HPMECs and F-actin remodeling. In vitro, UFH pretreatment inhibited LPS-induced increase in monomeric tubulin expression and decrease in tubulin polymerization and acetylation. Meanwhile, UFH ameliorates nocodazole-induced MTs disassembly and endothelial barrier dysfunction.Additionally, UFH decreased p38 phosphorylation and activation, which was similar to the effect of the p38 MAPK inhibitor, SB203580.

conclusionsUFH exert its protective effects on pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization and is associated with the p38 MAPK pathway.

Indexed as

Acute Lung InjuryAnimalsCapillary PermeabilityEndothelium, VascularHeparinHumansMaleMiceMice, Inbred C57BLMicrotubulesMicrovesselsProtein StabilityHeparinALICell cytoskeletonEndothelial permeabilityGEF-H1MicrotubuleUnfractionated heparin

Identifiers

PMID30442128
PMCPMC6238311
OpenAlexW2901554184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.